Tuesday, August 01, 2023 7:46:18 AM
It's funny that one remark you make is to warn all longs to exit once this stock has one final pump above $1.
There must be a plan in place to try and shift the wealth away from longs into your masters hands once we start to hear some positive news. No doubt that plan involves ridiculing the submission of the MAA and pounding the price one last time after the initial upsurge. No doubt this will involve shouting to the world that the MAA will be rejected in the UK and all other jurisdictions.
Your grand exit from this board is to try and create one last final statement of intent and that is to ensure that you leave enough doubt to try and unsettle some longs into letting go of what will be generational wealth if they hang onto those shares.
You and your masters have seriously under estimated the strength and perseverance of NWBO and it's shareholders.
You are about to find out just how serious of a position you are all in. IMO.
There must be a plan in place to try and shift the wealth away from longs into your masters hands once we start to hear some positive news. No doubt that plan involves ridiculing the submission of the MAA and pounding the price one last time after the initial upsurge. No doubt this will involve shouting to the world that the MAA will be rejected in the UK and all other jurisdictions.
Your grand exit from this board is to try and create one last final statement of intent and that is to ensure that you leave enough doubt to try and unsettle some longs into letting go of what will be generational wealth if they hang onto those shares.
You and your masters have seriously under estimated the strength and perseverance of NWBO and it's shareholders.
You are about to find out just how serious of a position you are all in. IMO.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
